Boston, MA -- (SBWIRE) -- 08/28/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Orexigen Therapeutics, Inc. (NASDAQ:OREX), Spirit Realty Capital Inc (NYSE:SRC), Ion Geophysical Corp (NYSE:IO), CYS Investments Inc(NYSE:CYS)
Orexigen Therapeutics, Inc. (NASDAQ:OREX) shares dropped 7.46% and closed at $6.70. The company on August 27 announced that the Light Study independent Data Monitoring Committee has recently confirmed that sufficient major adverse cardiovascular events (MACE) are expected to occur within the next two months, enabling the interim analysis to be conducted by early December and the potential resubmission of the Contrave New Drug Application (NDA) by year end. The DMC also recommended that the Light Study continue as planned with no changes to the protocol.
How Should Investors Trade OREX After The Recent Volatility? Get Free Report Here
Spirit Realty Capital Inc (NYSE:SRC) shares declined 1.02% to $8.71. The company on August 8 said second-quarter funds from operations, or FFO, was $21.4 million or $0.25 per share from $19.4 million or $0.49 per share in the same period last year. Adjusted FFO for the quarter was $37.9 million or $0.45 per share. Analysts expected the company to earn $0.19 per share for the quarter. Second-quarter loss widened to $11.7 million or $0.14 per share from $8.8 million or $0.34 per share last year. Revenues totaled $72.8 million, up 7.2 percent from $68.0 million. Analysts expected revenues of $73.22 million.
How Should Investors Trade SRC After The Recent Volatility? Get Free Report Here
Ion Geophysical Corp (NYSE:IO) shares fell 1.91% and closed at $4.63. The company on August 7 reported second quarter 2013 revenues of $120.9 million, a 15% increase from revenues of $105.2 million in second quarter 2012. Including the legal accrual, ION reported a net loss of $(71.1) million, or $(0.45) per diluted share, in the second quarter. Excluding the legal accrual, net income was $0.4 million, or $0.00 per diluted share, compared to net income of $12.0 million, or $0.08 per diluted share, in second quarter 2012.
Is IO A Good Buy After The Recent Price Movement? Find Out Here
CYS Investments Inc(NYSE:CYS) shares jumped 3.99% to $7.81. The company announced that Kevin E. Grant, CFA, the Company's CEO and President, will deliver a presentation at the Barclays Global Financial Services Conference at The New York Hilton Midtown on Tuesday, September 10, 2013 at approximately 8:15 a.m. (ET).
Additionally, CYS’s stock was downgraded by equities researchers at Maxim Group from a “buy” rating to a “hold” rating in a research report issued on August 13. They currently have a $10.00 target price on the stock.
Is CYS A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)